tiprankstipranks
Trending News
More News >

YiChang HEC ChangJiang Pharmaceutical’s Proposed Privatization Update

Story Highlights
YiChang HEC ChangJiang Pharmaceutical’s Proposed Privatization Update

Don’t Miss TipRanks’ Half-Year Sale

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has shared an announcement.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is undergoing a proposed pre-conditional privatization by Sunshine Lake Pharma Co., Ltd. through a merger by absorption. The merger is contingent upon fulfilling several pre-conditions, including obtaining necessary governmental approvals and listing permissions. As of the latest update, the NDRC approval has been obtained, but other approvals and conditions are still pending. The merger’s completion remains uncertain, and stakeholders are advised to stay informed about further announcements regarding the fulfillment of these conditions.

More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company based in China, focusing on the development, production, and sale of pharmaceutical products. The company operates within the healthcare industry, serving both domestic and international markets.

YTD Price Performance: -2.09%

Average Trading Volume: 3,297,522

Technical Sentiment Signal: Buy

Current Market Cap: HK$8.24B

Find detailed analytics on 1558 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1